应对中国结核病/耐多药结核病的挑战：采取一致行动势在必行。
Tackling challenges of TB/MDRTB in China: concerted actions are imperative.
作者信息
Tang Shenglan
机构信息
Duke Global Health Institute, Duke University, Durham, USA ; Duke Kunshan University, Global Health Research Center, Kunshan, China.
出版信息
Infect Dis Poverty. 2015 Apr 16;4:19. doi: 10.1186/s40249-015-0050-4. eCollection 2015.
Abstract
China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR). Over the past decade, a large number of TB control projects have been funded by the government of China and international organizations, and epidemic in China has been effectively controlled. However TB control in China still faced many challenges. Strategies to address these challenges may include integrating the national TB control program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in national TB control program, and reforming payment methods for TB care as part of health system reform in China.
摘要
中国是结核病疫情第二严重的国家，耐多药感染者数量最多。在过去十年里，中国政府和国际组织资助了大量结核病控制项目，中国的疫情得到了有效控制。然而，中国的结核病控制仍面临许多挑战。应对这些挑战的策略可能包括将国家结核病控制项目纳入医疗保险计划，通过让中国医院参与国家结核病控制项目来加强结核病病例管理，以及作为中国卫生系统改革的一部分改革结核病治疗的支付方式。
相似文献
1
Tackling challenges of TB/MDRTB in China: concerted actions are imperative.
Infect Dis Poverty. 2015 Apr 16;4:19. doi: 10.1186/s40249-015-0050-4. eCollection 2015.
2
Multi-source financing for tuberculosis treatment in China: key issues and challenges.
Infect Dis Poverty. 2021 Mar 10;10(1):17. doi: 10.1186/s40249-021-00809-4.
3
What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective.
Health Policy. 2005 Apr;72(1):93-104. doi: 10.1016/j.healthpol.2004.06.009.
4
[Exogenous re-infection in tuberculosis].
Kekkaku. 2006 Feb;81(2):79-91.
5
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
6
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
BMC Microbiol. 2016 May 12;16:85. doi: 10.1186/s12866-016-0699-2.
7
Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
Tuberculosis (Edinb). 2015 May;95(3):315-20. doi: 10.1016/j.tube.2015.02.041. Epub 2015 Feb 21.
8
Anti-tuberculosis drug resistance patterns and trends in a tuberculosis referral hospital, 1997-2009.
Epidemiol Infect. 2011 Dec;139(12):1909-18. doi: 10.1017/S0950268810003158. Epub 2011 Jan 27.
9
The burden of MDR/XDR tuberculosis in coastal plains population of China.
PLoS One. 2015 Feb 17;10(2):e0117361. doi: 10.1371/journal.pone.0117361. eCollection 2015.
10
[How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].
Kekkaku. 2005 Feb;80(2):89-94.
引用本文的文献
1
Influence of Public Health Services on the Goal of Ending Tuberculosis: Evidence From Panel Data in China.
Front Public Health. 2022 Mar 4;10:826800. doi: 10.3389/fpubh.2022.826800. eCollection 2022.
2
Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities.
Risk Manag Healthc Policy. 2020 Nov 2;13:2387-2394. doi: 10.2147/RMHP.S275400. eCollection 2020.
3
Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.
Infect Dis Poverty. 2019 Oct 4;8(1):79. doi: 10.1186/s40249-019-0590-0.
4
The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients.
Infect Dis Poverty. 2019 Aug 2;8(1):67. doi: 10.1186/s40249-019-0575-z.
5
Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor?
Infect Dis Poverty. 2019 Mar 24;8(1):21. doi: 10.1186/s40249-019-0532-x.
6
Multidrug-resistant tuberculosis in rural China: lack of public awareness, unaffordable costs and poor clinical management.
BMJ Case Rep. 2018 Aug 11;2018:bcr-2018-225794. doi: 10.1136/bcr-2018-225794.
7
Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
BMC Public Health. 2017 Feb 22;17(1):221. doi: 10.1186/s12889-017-4089-y.
8
Spatial transmission and meteorological determinants of tuberculosis incidence in Qinghai Province, China: a spatial clustering panel analysis.
Infect Dis Poverty. 2016 Jun 2;5(1):45. doi: 10.1186/s40249-016-0139-4.
9
The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China.
Infect Dis Poverty. 2016 Jan 28;5:8. doi: 10.1186/s40249-015-0094-5.
10
Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China.
Infect Dis Poverty. 2016 Jan 27;5:7. doi: 10.1186/s40249-016-0102-4.
本文引用的文献
1
Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China.
Infect Dis Poverty. 2015 Mar 24;4:14. doi: 10.1186/s40249-015-0045-1. eCollection 2015.
2
Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis.
BMC Med. 2013 Jul 2;11:156. doi: 10.1186/1741-7015-11-156.
3
The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries.
Health Policy Plan. 2014 May;29(3):367-78. doi: 10.1093/heapol/czt023. Epub 2013 Apr 23.
4
National survey of drug-resistant tuberculosis in China.
N Engl J Med. 2012 Jun 7;366(23):2161-70. doi: 10.1056/NEJMoa1108789.
5
Expanding health insurance coverage in vulnerable groups: a systematic review of options.
Health Policy Plan. 2011 Mar;26(2):93-104. doi: 10.1093/heapol/czq038. Epub 2010 Sep 2.
Zotero 插件